Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Marfan Syndrome | 4 | 2018 | 143 | 0.480 |
Why?
|
| Atenolol | 4 | 2018 | 43 | 0.450 |
Why?
|
| Losartan | 4 | 2018 | 36 | 0.440 |
Why?
|
| Aortic Diseases | 2 | 2018 | 203 | 0.240 |
Why?
|
| Aorta | 3 | 2018 | 561 | 0.230 |
Why?
|
| Specialization | 1 | 2003 | 82 | 0.200 |
Why?
|
| Catheterization | 2 | 2016 | 236 | 0.200 |
Why?
|
| Medicine | 1 | 2003 | 108 | 0.190 |
Why?
|
| Thrombosis | 2 | 2018 | 539 | 0.190 |
Why?
|
| Adenoviridae | 2 | 2016 | 610 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2003 | 471 | 0.150 |
Why?
|
| Antihypertensive Agents | 2 | 2018 | 410 | 0.150 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2018 | 57 | 0.150 |
Why?
|
| Blood Vessels | 1 | 2017 | 108 | 0.140 |
Why?
|
| Vascular Stiffness | 1 | 2018 | 80 | 0.130 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2016 | 10 | 0.130 |
Why?
|
| alpha-Glucosidases | 1 | 2016 | 29 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 144 | 0.130 |
Why?
|
| Asthma | 1 | 2003 | 815 | 0.120 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2016 | 129 | 0.120 |
Why?
|
| Thrombectomy | 1 | 2016 | 104 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2016 | 168 | 0.110 |
Why?
|
| Stents | 2 | 2017 | 877 | 0.110 |
Why?
|
| Genetic Therapy | 2 | 2016 | 733 | 0.110 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2014 | 42 | 0.110 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2014 | 88 | 0.100 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 559 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 252 | 0.100 |
Why?
|
| Pulmonary Valve | 1 | 2014 | 96 | 0.100 |
Why?
|
| Hemophilia B | 1 | 2012 | 8 | 0.100 |
Why?
|
| Factor IX | 1 | 2012 | 15 | 0.100 |
Why?
|
| Genetic Vectors | 2 | 2016 | 970 | 0.100 |
Why?
|
| Aortic Aneurysm | 1 | 2014 | 234 | 0.090 |
Why?
|
| Transposition of Great Vessels | 1 | 2012 | 133 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 976 | 0.090 |
Why?
|
| Liver | 2 | 2016 | 1877 | 0.090 |
Why?
|
| Macaca mulatta | 1 | 2012 | 514 | 0.090 |
Why?
|
| Heart Valve Prosthesis | 1 | 2014 | 309 | 0.090 |
Why?
|
| Heart Defects, Congenital | 3 | 2017 | 1874 | 0.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2014 | 452 | 0.080 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 1093 | 0.080 |
Why?
|
| Endovascular Procedures | 1 | 2017 | 775 | 0.080 |
Why?
|
| Palliative Care | 1 | 2012 | 461 | 0.070 |
Why?
|
| Quality of Life | 1 | 2018 | 2147 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2012 | 799 | 0.070 |
Why?
|
| Child, Preschool | 6 | 2018 | 14805 | 0.070 |
Why?
|
| Adolescent | 7 | 2018 | 20522 | 0.070 |
Why?
|
| Prosthesis Design | 2 | 2018 | 660 | 0.060 |
Why?
|
| Heart Failure | 1 | 2018 | 2423 | 0.060 |
Why?
|
| Helper Viruses | 2 | 2016 | 46 | 0.060 |
Why?
|
| Linear Models | 2 | 2018 | 722 | 0.060 |
Why?
|
| Child | 7 | 2018 | 25762 | 0.050 |
Why?
|
| Nasal Polyps | 1 | 2003 | 25 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2012 | 1159 | 0.050 |
Why?
|
| Male | 10 | 2018 | 65798 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2003 | 188 | 0.050 |
Why?
|
| Sinusitis | 1 | 2003 | 116 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2018 | 12988 | 0.050 |
Why?
|
| Female | 9 | 2018 | 71548 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2003 | 239 | 0.050 |
Why?
|
| Hypersensitivity | 1 | 2003 | 196 | 0.040 |
Why?
|
| Infant | 4 | 2018 | 13173 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2003 | 401 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2003 | 395 | 0.040 |
Why?
|
| Survival Rate | 2 | 2018 | 2211 | 0.040 |
Why?
|
| Gastroesophageal Reflux | 1 | 2003 | 336 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2018 | 3085 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2003 | 1255 | 0.040 |
Why?
|
| Young Adult | 3 | 2018 | 9875 | 0.040 |
Why?
|
| Humans | 10 | 2018 | 133564 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2018 | 3700 | 0.040 |
Why?
|
| Dilatation | 1 | 2018 | 71 | 0.040 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2018 | 29 | 0.040 |
Why?
|
| Health Status Indicators | 1 | 2018 | 130 | 0.040 |
Why?
|
| Infant, Newborn | 3 | 2017 | 8592 | 0.040 |
Why?
|
| Adult | 4 | 2018 | 31842 | 0.040 |
Why?
|
| Length of Stay | 2 | 2014 | 1383 | 0.030 |
Why?
|
| Risk Factors | 3 | 2018 | 11098 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2017 | 17402 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 241 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2018 | 204 | 0.030 |
Why?
|
| Papio | 1 | 2016 | 60 | 0.030 |
Why?
|
| ROC Curve | 1 | 2018 | 609 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 756 | 0.030 |
Why?
|
| Phlebography | 1 | 2016 | 45 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 92 | 0.030 |
Why?
|
| Vascular Access Devices | 1 | 2016 | 36 | 0.030 |
Why?
|
| Diaphragm | 1 | 2016 | 99 | 0.030 |
Why?
|
| Angioplasty | 1 | 2016 | 80 | 0.030 |
Why?
|
| Vascular Patency | 1 | 2016 | 198 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 1139 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2016 | 4838 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2018 | 569 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1735 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 1485 | 0.030 |
Why?
|
| Equipment Design | 1 | 2016 | 604 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2018 | 600 | 0.030 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2014 | 155 | 0.030 |
Why?
|
| Echocardiography | 1 | 2018 | 1125 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 971 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 1468 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2012 | 296 | 0.020 |
Why?
|
| Transgenes | 1 | 2012 | 346 | 0.020 |
Why?
|
| Myocardium | 1 | 2016 | 1045 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 3174 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2016 | 1041 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2988 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 5076 | 0.020 |
Why?
|
| Mice | 2 | 2016 | 18935 | 0.020 |
Why?
|
| Obesity | 1 | 2018 | 2429 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 6577 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 2653 | 0.010 |
Why?
|
| Middle Aged | 1 | 2003 | 29264 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5461 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 36407 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 4790 | 0.010 |
Why?
|